References
- Yancy CW Jessup M Bozkurt B 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 2013 Oct 15 128 16 e240 327
- Arbustini E Narula N Tavazzi L The MOGE(S) classification of cardiomyopathy for clinicians J Am Coll Cardiol 2014 Jul 22 64 3 304 18
- Senthilkumar A Majmudar MD Shenoy C Kim HW Kim RJ Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance Heart Fail Clin 2009 Jul 5 3 349 67 vi
- Schuster A Morton G Chiribiri A Perera D Vanoverschelde JL Nagel E Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance J Am Coll Cardiol 2012 Jan 24 59 4 359 70
- Kim RJ Wu E Rafael A The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 2000 Nov 16 343 20 1445 53
- Manning WJ Atkinson DJ Grossman W Paulin S Edelman RR First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease J Am Coll Cardiol 1991 Oct 18 4 959 65
- Soriano CJ Ridocci F Estornell J Noninvasive Diagnosis of Coronary Artery Disease in Patients With Heart Failure and Systolic Dysfunction of Uncertain Etiology, Using Late Gadolinium-Enhanced Cardiovascular Magnetic Resonance J Am Coll Cardiol 2005 Mar 1 45 5 743 8
- Pasupathy S Tavella R Beltrame JF The What, When, Who, Why, How and Where of Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) Circ J 2016 80 1 11 6
- Gersh BJ Maron BJ Bonow RO 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 2011 Dec 13 124 24 2761 96
- Elliott PM Anastasakis A Borger MA 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 2014 Oct 14 35 39 2733 79
- Henry WL Clark CE Epstein SE Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS Circulation 1973 Feb 47 2 225 33
- Doi YL Deanfield JE McKenna WJ Dargie HJ Oakley CM Goodwin JF Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy Br Heart J 1980 Oct 44 4 395 400
- Rickers C Wilke NM Jerosch-Herold M Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 2005 Aug 9 112 6 855 61
- Ismail TF Hsu LY Greve AM Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study J Cardiovasc Magn Reson 2014 Aug 12 16 49
- Chan RH Maron BJ Olivotto I Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy Circulation 2014 Aug 5 130 6 484 95
- Rowin EJ Maron BJ Haas TS Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management J Am Coll Cardiol 2017 Feb 21 69 7 761 73
- Muchtar E Blauwet LA Gertz MA Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy Circ Res 2017 Sep 15 121 7 819 37
- Maceira AM Joshi J Prasad SK Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 2005 Jan 18 111 2 186 93
- Vogelsberg H Mahrholdt H Deluigi CC Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy J Am Coll Cardiol 2008 Mar 11 51 10 1022 30
- Brooks J Kramer CM Salerno M Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping J Magn Reson Imaging 2013 Dec 38 6 1591 5
- Banypersad SM Sado DM Flett AS Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study Circ Cardiovasc Imaging 2013 Jan 1 6 1 34 9
- Fontana M Banypersad SM Treibel TA Native T1 mapping in transthyretin amyloidosis JACC Cardiovasc Imaging 2014 Feb 7 2 157 65
- Dungu JN Valencia O Pinney JH CMR-based differentiation of AL and ATTR cardiac amyloidosis JACC Cardiovasc Imaging 2014 Feb 7 2 133 42
- Kellman P Wilson JR Xue H Ugander M Arai AE Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method J Cardiovasc Magn Reson 2012 Sep 10 14 63
- Kellman P Wilson JR Xue H Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience J Cardiovasc Magn Reson 2012 Sep 11 14 64
- Patel MR Cawley PJ Heitner JF Detection of myocardial damage in patients with sarcoidosis Circulation 2009 Nov 17 120 20 1969 77
- Terasaki F Azuma A Anzai T JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis-Digest Version Circ J 2019 Oct 25 83 11 2329 88
- Birnie DH Sauer WH Bogun F HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis Heart Rhythm 2014 Jul 11 7 1305 23
- Crouser ED Ruden E Julian MW Raman SV Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis J Investig Med 2016 Aug 64 6 1148 50
- Modell B Khan M Darlison M Westwood MA Ingram D Pennell DJ Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance J Cardiovasc Magn Reson 2008 Sep 25 10 42
- Sado DM Maestrini V Piechnik SK Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload J Magn Reson Imaging 2015 Jun 41 6 1505 11
- Messroghli DR Moon JC Ferreira VM Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) J Cardiovasc Magn Reson 2017 Oct 9 19 1 75
- Moon JC Sheppard M Reed E Lee P Elliott PM Pennell DJ The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease J Cardiovasc Magn Reson 2006 8 3 479 82
- Thompson RB Chow K Khan A T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex Circ Cardiovasc Imaging 2013 Sep 6 5 637 45
- Mocumbi AO Ferreira MB Sidi D Yacoub MH A population study of endomyocardial fibrosis in a rural area of Mozambique N Engl J Med 2008 Jul 3 359 1 43 9
- Marcus FI McKenna WJ Sherrill D Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria Circulation 2010 Apr 6 121 13 1533 41
- Samsa LA Yang B Liu J Embryonic cardiac chamber maturation: Trabeculation, conduction, and cardiomyocyte proliferation Am J Med Genet C Semin Med Genet 2013 Aug 163C 3 157 68
- Ulusoy RE Kucukarslan N Kirilmaz A Demiralp E Noncompaction of ventricular myocardium involving both ventricles Eur J Echocardiogr 2006 Dec 7 6 457 60
- Hofer M Stollberger C Finsterer J Acquired noncompaction associated with myopathy Int J Cardiol 2007 Oct 18 121 3 296 7
- Gati S Chandra N Bennett RL Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular noncompaction in athletes? Heart 2013 Mar 99 6 401 8
- Petersen SE Selvanayagam JB Wiesmann F Left ventricular noncompaction: insights from cardiovascular magnetic resonance imaging J Am Coll Cardiol 2005 Jul 5 46 1 101 5
- Jacquier A Thuny F Jop B Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular noncompaction Eur Heart J 2010 May 31 9 1098 104
- Captur G Muthurangu V Cook C Quantification of left ventricular trabeculae using fractal analysis J Cardiovasc Magn Reson 2013 May 10 15 36
- Elliott P Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy Heart 2000 Jul 84 1 106 12
- Rossi A Dini FL Faggiano P Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy Heart 2011 Oct 97 20 1675 80
- de Leeuw N Ruiter DJ Balk AH de Jonge N Melchers WJ Galama JM Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy Transpl Int 2001 Sep 14 5 299 306
- Iles L Pfluger H Lefkovits L Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 2011 Feb 15 57 7 821 8
- Assomull RG Prasad SK Lyne J Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 2006 Nov 21 48 10 1977 85
- Gulati A Jabbour A Ismail TF Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy JAMA 2013 Mar 6 309 9 896 908
- Leong DP Chakrabarty A Shipp N Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography Eur Heart J 2012 Mar 33 5 640 8
- Masci PG Schuurman R Andrea B Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study Circ Cardiovasc Imaging 2013 Sep 6 5 790 9
- Leyva F Taylor RJ Foley PW Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy J Am Coll Cardiol 2012 Oct 23 60 17 1659 67
- Ferreira VM Schulz-Menger J Holmvang G Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations J Am Coll Cardiol 2018 Dec 18 72 24 3158 76
- Mahrholdt H Wagner A Deluigi CC Presentation, patterns of myocardial damage, and clinical course of viral myocarditis Circulation 2006 Oct 10 114 15 1581 90
DOI: https://doi.org/10.14797/mdcj-16-2-97 | Journal eISSN: 1947-6108
Language: English
Page range: 97 - 105
Published on: Apr 1, 2020
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2020 Eric Y. Yang, Dipan J. Shah, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.